Immunohistochemistry of the right breast showed estrogen receptor (ER) negative, progesterone receptor (PR) negative, HER2 negative, and Ki67 immunoreactive in 25% of tumor cell nuclei (Fig. 3). This evidence concerns the gene ERBB2 and neoplasm.